[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate

C25H40O3 — CID 90391869

IUPAC[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate
SMILESC=C[C@@H](C)[C@H]1CCC2C3C[C@H](OC(C)=O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@@]21C
InChIInChI=1S/C25H40O3/c1-6-15(2)19-7-8-20-18-14-23(28-16(3)26)22-13-17(27)9-11-25(22,5)21(18)10-12-24(19,20)4/h6,15,17-23,27H,1,7-14H2,2-5H3/t15-,17-,18?,19-,20?,21?,22+,23+,24-,25-/m1/s1
InChIKeyQEKPVNYUWJUMCT-HXPPYBRWSA-N
MW388.59 g/mol
LogP5.37
Rot. Bonds3

About [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate

[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate (PubChem CID 90391869) has the molecular formula C25H40O3 and a molecular weight of 388.59 g/mol. Its IUPAC name is [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate.

Molecular Properties

Compound Name[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate
PubChem CID90391869
Molecular FormulaC25H40O3
Molecular Weight388.59 g/mol
Exact Mass388.30
IUPAC Name[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate
SMILESC=C[C@@H](C)[C@H]1CCC2C3C[C@H](OC(C)=O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@@]21C
InChIInChI=1S/C25H40O3/c1-6-15(2)19-7-8-20-18-14-23(28-16(3)26)22-13-17(27)9-11-25(22,5)21(18)10-12-24(19,20)4/h6,15,17-23,27H,1,7-14H2,2-5H3/t15-,17-,18?,19-,20?,21?,22+,23+,24-,25-/m1/s1
InChIKeyQEKPVNYUWJUMCT-HXPPYBRWSA-N
XLogP5.37
TPSA46.53 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds3
Heavy Atoms28
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500388.59
LogP ≤ 55.37
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate?
The IUPAC name of [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate (CID 90391869) is [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate.
What is the SMILES notation for [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate?
The canonical SMILES for [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate is C=C[C@@H](C)[C@H]1CCC2C3C[C@H](OC(C)=O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@@]21C.
What is the InChIKey of [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate?
The InChIKey is QEKPVNYUWJUMCT-HXPPYBRWSA-N. The full InChI is InChI=1S/C25H40O3/c1-6-15(2)19-7-8-20-18-14-23(28-16(3)26)22-13-17(27)9-11-25(22,5)21(18)10-12-24(19,20)4/h6,15,17-23,27H,1,7-14H2,2-5H3/t15-,17-,18?,19-,20?,21?,22+,23+,24-,25-/m1/s1.
What are the key properties of [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate?
[(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate has a molecular weight of 388.59 g/mol, XLogP of 5.37, 3 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R,5R,6S,10R,13R,17R)-17-[(2R)-but-3-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate is sourced from PubChem (CID 90391869), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).